Hydrogen sulfide and PKG in ischemia–reperfusion injury: sources, signaling, accelerators and brakes

Basic Research in Cardiology

Volumn 110, Issue 5, 2015, Pages

  Andreadou, Ioanna ^a   Iliodromitis, Efstathios K ^b   Szabo, Csaba ^c   Papapetropoulos, Andreas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cardioprotection; Hydrogen sulfide; Ischemia reperfusion; Myocardial infarction; Nitric oxide; PKG

Indexed keywords

CINACIGUAT; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; OXYGEN; SULFURTRANSFERASE;

DNA FLANKING REGION; DOWNSTREAM PROCESSING; EDITORIAL; HEART INFARCTION; HEART PROTECTION; HUMAN; NEUROMODULATION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; VASODILATATION; ANIMAL; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC GMP-DEPENDENT PROTEIN KINASES; HUMANS; HYDROGEN SULFIDE; MYOCARDIAL REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84941616201     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-015-0510-9     Document Type: Editorial

References (52)

1. Abe K, Kimura H (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16:1066–1071
2. Altaany Z, Ju Y, Yang G, Wang R (2014) The coordination of S-sulfhydration, S-nitrosylation, and phosphorylation of endothelial nitric oxide synthase by hydrogen sulfide. Sci Signal 7:ra87. doi:10.1126/scisignal.2005478
3. Andreadou I, Iliodromitis EK, Rassaf T, Schulz R, Papapetropoulos A, Ferdinandy P (2015) The role of gasotransmitters NO, H2S, CO in myocardial ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Br J Pharmacol 172:1587–1606. doi:10.1111/bph.12811
4. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S, Moore PK (2006) Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316:670–678. doi:10.1124/jpet.105.092023
5. Bibli SI, Andreadou I, Chatzianastasiou A, Tzimas C, Sanoudou D, Kranias E, Brouckaert P, Coletta C, Szabo C, Kremastinos DT, Iliodromitis EK, Papapetropoulos A (2015) Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway. Cardiovasc Res 106:432–442. doi:10.1093/cvr/cvv129
6. Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Pyriochou A, Roussos C, Roviezzo F, Brancaleone V, Girino G (2010) Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 30:1998–2004. doi:10.1161/ATVBAHA.110.209783
7. Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Zaid A, Giannogonas P, Cantalupo A, Dhayade S, Karalis KP, Wang W, Feil R, Cirino G (2012) cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation. PLoS One 7:e53319. doi:10.1371/journal.pone.0053319
8. Bucci M, Vellecco V, Cantalupo A, Brancaleone V, Zhou Z, Evangelista S, Calderone V, Papapetropoulos A, Cirino G (2014) Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. Cardiovasc Res 102:138–147. doi:10.1093/cvr/cvu026
9. Burley DS, Ferdinandy P, Baxter GF (2007) Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 152:855–869. doi:10.1038/sj.bjp.0707409
10. Burley DS, Cox CD, Zhang J, Wann KT, Baxter GF (2014) Natriuretic peptides modulate ATP-sensitive K(+) channels in rat ventricular cardiomyocytes. Basic Res Cardiol 109:402–416. doi:10.1007/s00395-014-0402-4
11. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, Lefer DJ (2009) Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105:365–374. doi:10.1161/CIRCRESAHA.109.199919
12. Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, Elrod JW, Ramachandran A, Lefer DJ (2010) Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 122:11–19. doi:10.1161/CIRCULATIONAHA.109.920991
13. Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, James AM, Cochemé HM, Reinhold J, Lilley KS, Partridge L, Fearnley IM, Robinson AJ, Hartley RC, Smith RA, Krieg T, Brookes PS, Murphy MP (2013) Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med 19:753–759. doi:10.1038/nm.3212
14. Cohen MV, Yang XM, Liu Y, Solenkova NV, Downey JM (2010) Cardioprotective PKG-independent NO signaling at reperfusion. Am J Physiol Heart Circ Physiol 299:H2028–H2036. doi:10.1152/ajpheart.00527.2010
15. Coletta C, Papapetropoulos A, Erdelyi K, Olah G, Módis K, Panopoulos P, Asimakopoulou A, Gerö D, Sharina I, Martin E, Szabo C (2012) Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci USA 109:9161–9166. doi:10.1073/pnas.1202916109
16. Das A, Samidurai A, Hoke NN, Kukreja RC, Salloum FN (2015) Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα. Basic Res Cardiol 110:42–53. doi:10.1007/s00395-015-0500-y
17. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ (2007) Hydrogen sulfide attenuates myocardial ischemia–reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104:15560–15565. doi:10.1073/pnas.0705891104
18. Fraccarollo D, Galuppo P, Motschenbacher S, Ruetten H, Schäfer A, Bauersachs J (2014) Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction: cardioprotection over ACE inhibition. Basic Res Cardiol 109:421. doi:10.1007/s00395-014-0421-1
19. Garcia-Dorado D, Agulló L, Sartorio CL, Ruiz-Meana M (2009) Myocardial protection against reperfusion injury: the cGMP pathway. Thromb Haemost 101:635–642. doi:10.1160/TH08-11-0764
20. Greiner R, Pálinkás Z, Bäsell K, Becher D, Antelmann H, Nagy P, Dick TP (2013) Polysulfides link H2S to protein thiol oxidation. Antioxid Redox Signal 19:1749–1765. doi:10.1089/ars.2012.5041
21. Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116:674–699. doi:10.1161/CIRCRESAHA.116.305348
22. Hosoki R, Matsuki N, Kimura H (1997) The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237:527–531. doi:10.1006/bbrc.1997.6878
23. Inserte J, Barba I, Poncelas-Nozal M, Hernando V, Agullo L, Ruiz-Meana M, Garcia-Dorado D (2011) cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion. J Mol Cell Cardiol 50:903–909. doi:10.1016/j.yjmcc.2011.02.013
24. Inserte J, Hernando V, Ruiz-Meana M, Poncelas-Nozal M, Fernandez C, Agullo L, Sartorio C, Vilardosa U, Garcia-Dorado D (2014) Delayed phospholamban phosphorylation in post-conditioned heart favours Ca2+ normalization and contributes to protection. Cardiovasc Res 103:542–553. doi:10.1093/cvr/cvu163
25. Ishii I, Akahoshi N, Yu XN, Kobayashi Y, Namekata K, Komaki G, Kimura H (2004) Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem J 381:113–123. doi:10.1042/BJ20040243
26. Johansen D, Ytrehus K, Baxter GF (2006) Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury—Evidence for a role of K ATP channels. Basic Res Cardiol 101:53–60. doi:10.1007/s00395-005-0569-9
27. Kabil O, Banerjee R (2014) Enzymology of H2S biogenesis, decay and signaling. Antioxid Redox Signal 20:770–782. doi:10.1089/ars.2013.5339
28. King AL, Polhemus DJ, Bhushan S, Otsuka H, Kondo K, Nicholson CK, Bradley JM, Islam KN, Calvert JW, Tao YX, Dugas TR, Kelley EE, Elrod JW, Huang PL, Wang R, Lefer DJ (2014) Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase nitric oxide dependent. Proc Natl Acad Sci USA 111:3182–3187. doi:10.1073/pnas.1321871111
29. Kondo K, Bhushan S, King AL, Prabhu SD, Hamid T, Koenig S, Murohara T, Predmore BL, Gojon G Jr, Gojon G Sr, Wang R, Karusula N, Nicholson CK, Calvert JW, Lefer DJ (2013) H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 127:1116–1127. doi:10.1161/CIRCULATIONAHA.112.000855
30. Kranias EG, Hajjar RJ (2012) Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ Res 110:1646–1660. doi:10.1161/CIRCRESAHA.111.259754
31. Methner C, Lukowski R, Grube K, Loga F, Smith RA, Murphy MP, Hofmann F, Krieg T (2013) Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G. Basic Res Cardiol 108:337. doi:10.1007/s00395-013-0337-1
32. Minamishima S, Kida K, Tokuda K, Wang H, Sips PY, Kosugi S, Mandeville JB, Buys ES, Brouckaert P, Liu PK, Liu CH, Bloch KD, Ichinose F (2011) Inhaled nitric oxide improves outcomes after successful cardiopulmonary resuscitation in mice. Circulation 124:1645–1653. doi:10.1161/CIRCULATIONAHA.111.025395
33. Módis K, Panopoulos P, Coletta C, Papapetropoulos A, Szabo C (2013) Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A. Biochem Pharmacol 86:1311–1319. doi:10.1016/j.bcp.2013.08.064
34. Olson KR, Donald JA, Dombkowski RA, Perry SF (2012) Evolutionary and comparative aspects of nitric oxide, carbon monoxide and hydrogen sulfide. Respir Physiol Neurobiol 184:117–129. doi:10.1016/j.resp.2012.04.004
35. Panopoulos P, Yang G, Asimakopoulou A, Topouzis S, Wang R, Szabo C, Papapetropoulos A (2015) Selectivity of hydrogen sulfide towards cyclic nucleotide phosphodiesterases. Nitric Oxide 47:S39. doi:10.1016/j.niox.2015.02.095(abstract)
36. Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN, Wang R, Szabó C (2009) Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 106:21972–21977. doi:10.1073/pnas.0908047106
37. Papapetropoulos A, Whiteman M, Cirino G (2015) Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners. Br J Pharmacol 172:1633–1637. doi:10.1111/bph.12806
38. Polhemus DJ, Kondo K, Bhushan S, Bir SC, Kevil CG, Murohara T, Lefer DJ, Calvert JW (2013) Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogenesis. Circ Heart Fail 6:1077–1086. doi:10.1161/CIRCHEARTFAILURE.113.000299
39. Polhemus DJ, Lefer DJ (2014) Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ Res 114:730–737. doi:10.1161/CIRCRESAHA.114.300505
40. Predmore BL, Lefer DJ (2011) Hydrogen sulfide-mediated myocardial pre- and postconditioning. Expert Rev Clin Pharmacol 4:83–96. doi:10.1586/ecp.10.56
41. Predmore BL, Kondo K, Bhushan S, Zlatopolsky MA, King AL, Aragon JP, Grinsfelder DB, Condit ME, Lefer DJ (2012) The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability. Am J Physiol Heart Circ Physiol 302:H2410–H2418. doi:10.1152/ajpheart.00044.2012
42. Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC (2009) Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase G dependent generation of hydrogen sulfide. Circulation 120:S31–S36. doi:10.1161/CIRCULATIONAHA.108.843979
43. Salloum FN, Das A, Samidurai A, Hoke NN, Chau VQ, Ockaili RA, Stasch JP, Kukreja RC (2012) Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide. Am J Physiol Heart Circ Physiol 302:H1347–H1354. doi:10.1152/ajpheart.00544.2011
44. Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, Kim S, Snyder SH (2012) Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions. Mol Cell 45:13–24. doi:10.1016/j.molcel.2011.10.021
45. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R, Thiemermann C (2009) Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 31:267–274. doi:10.1097/SHK.0b013e318180ff89
46. Stubbert D, Prysyazhna O, Rudyk O, Scotcher J, Burgoyne JR, Eaton P (2014) Protein kinase G Ialpha oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide. Hypertension 64:1344–13451. doi:10.1161/HYPERTENSIONAHA.114.04281
47. Szabó G, Veres G, Radovits T, Gero D, Módis K, Miesel-Gröschel C, Horkay F, Karck M, Szabó C (2011) Cardioprotective effects of hydrogen sulfide. Nitric Oxide 25:201–210. doi:10.1016/j.niox.2010.11.001
48. Tsai CY, Wen S-Y, Shibu MA, Yang Y-C, Peng H, Wang B, Wei Y-M, Chang H-Y, Lee C-Y, Huang C-Y, Kuo W-W (2015) Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide. Int J Cardiol 195:300–310. doi:10.1016/j.ijcard.2015.05.111
49. Wallace JL, Wang R (2015) Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter. Nat Rev Drug Discov 14:329–345. doi:10.1038/nrd4433
50. Wang R (2012) Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev 92:791–896. doi:10.1152/physrev.00017.2011
51. Yuan G, Vasavda C, Peng Y-J, Makarenko VV, Raghuraman G, Nanduri J, Gadalla MM, Semenza GL, Kumar GK, Snyder SH, Prabhakar NR (2015) Protein kinase G regulated production of H2S governs oxygen sensing. Sci Signal 8:ra37. doi:10.1126/scisignal.2005846
52. Zhou Z, Sharina I, Bucci M, Cirino G, Martin E, Papapetropoulos A (2015) Hydrogen sulfide regulates the redox status of soluble guanylyl cyclase. Nitric Oxide 47:S34. doi:10.1016/j.niox.2015.02.082(abstract)